Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Cliff R Jack, Harald Hampel et al.|Alzheimer s & Dementia|2016Cited by 1.9k
Defeating Alzheimer's disease and other dementias: a priority for European science and societyBengt Winblad, Henrik Zetterberg, Howard Feldman et al.|The Lancet Neurology|2016Cited by 1.7k
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET imagesDonghuan Lu, Erin Franklin, Karteek Popuri et al.|Scientific Reports|2018Cited by 380
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression modelRandall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger et al.|Alzheimer s & Dementia|2016Cited by 303
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task ForceBruno Vellas, María C. Carrillo, Cristina Sampaio et al.|Alzheimer s & Dementia|2013Cited by 145